Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Expanded Access Trial
NCT00426660Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Feb 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Feb 2007; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00426660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426660.